These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19472013)

  • 1. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
    Chang SC; Lin PC; Yang SH; Wang HS; Li AF; Lin JK
    Ann Surg Oncol; 2009 Aug; 16(8):2323-30. PubMed ID: 19472013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.
    Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Dahiya AV; Suehiro Y; Tanaka Y; Dahiya R
    Clin Cancer Res; 2007 Sep; 13(17):5056-62. PubMed ID: 17785557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of CXCR4 and SDF-1alpha with organ-specific metastasis of nasopharyngeal carcinoma].
    Luo HN; Li XP; Liu X; Zhang GH; Liu YL
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):260-4. PubMed ID: 19615279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
    Dimberg J; Hugander A; Löfgren S; Wågsäter D
    Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.
    Zinzindohoué F; Lecomte T; Ferraz JM; Houllier AM; Cugnenc PH; Berger A; Blons H; Laurent-Puig P
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):594-9. PubMed ID: 15701845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis.
    Matsusue R; Kubo H; Hisamori S; Okoshi K; Takagi H; Hida K; Nakano K; Itami A; Kawada K; Nagayama S; Sakai Y
    Ann Surg Oncol; 2009 Sep; 16(9):2645-53. PubMed ID: 19588204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
    Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
    Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6.
    Wang B; Wang W; Niu W; Liu E; Liu X; Wang J; Peng C; Liu S; Xu L; Wang L; Niu J
    Carcinogenesis; 2014 Feb; 35(2):282-91. PubMed ID: 24085800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer.
    Hassan S; Baccarelli A; Salvucci O; Basik M
    Clin Cancer Res; 2008 Jan; 14(2):446-54. PubMed ID: 18223219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
    Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
    Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
    Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K
    J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.
    Bachmann HS; Otterbach F; Callies R; Nückel H; Bau M; Schmid KW; Siffert W; Kimmig R
    Clin Cancer Res; 2007 Oct; 13(19):5790-7. PubMed ID: 17908970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.